| | | | | | | |
 | JOHNSON & JOHNSON | 1.13% | 0.71% | 4.94% | 8.17% | 28.82% | 467 100 |
| ELI LILLY AND COMPANY | 0.15% | 5.32% | 17.55% | 40.49% | 188.02% | 291 859 |
 | ROCHE HOLDING AG | 0.58% | 4.00% | -15.48% | -8.08% | 16.66% | 272 586 |
| ABBVIE INC. | 0.42% | 2.48% | 13.59% | 34.61% | 109.54% | 270 651 |
 | NOVO NORDISK A/S | -0.33% | 3.19% | 6.75% | 49.33% | 134.56% | 251 273 |
| MERCK & CO., INC. | 1.37% | -0.90% | 20.59% | 18.50% | 9.05% | 230 551 |
 | ASTRAZENECA PLC | -0.72% | 3.99% | 23.55% | 23.48% | 66.54% | 203 345 |
| NOVARTIS AG | -0.64% | 3.35% | 0.06% | -4.73% | -9.94% | 183 899 |
| BRISTOL-MYERS SQUIBB COMPANY | -0.21% | -0.89% | 23.24% | 15.44% | 66.39% | 163 938 |
| AMGEN INC. | 0.92% | 0.09% | 9.15% | -0.55% | 31.77% | 129 971 |
 | SANOFI | 1.22% | 0.62% | 10.09% | 10.37% | 28.47% | 125 932 |
| GSK PLC | 1.13% | 2.21% | 11.14% | 25.80% | 13.26% | 108 565 |
 | BAYER AG | 1.11% | -3.11% | 22.02% | 10.44% | -6.46% | 58 251 |
 | DAIICHI SANKYO CO., LTD. | -1.77% | 6.15% | 15.42% | 40.99% | 79.73% | 48 480 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | -1.55% | 3.05% | 19.83% | 1.08% | -1.67% | 43 368 |
| | | | | | | |
| | Promedio | 0.19% | 2.02% | 12.16% | 17.69% | 50.31% | |
| | Media ponderada por Capi. | 0.38% | 2.14% | 10.00% | 18.45% | 60.91% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Reporte
